Peer-reviewed Articles 2014

  • Vitrac C, Peron S, Frappe I, Fernagut PO, Jaber M, Gaillard A, Benoit-Marand M (2014) Dopamine control of pyramidal neuron activity in the primary motor cortex via D2 receptors. Frontiers in neural circuits 8:13.
  • Balbous A, Cortes U, Guilloteau K, Villalva C, Flamant S, Gaillard A, Milin S, Wager M, Sorel N, Guilhot J, Bennaceur-Griscelli A, Turhan A, Chomel JC, Karayan-Tapon L. A mesenchymal glioma stem cell profile is related to clinical outcome. Oncogenesis. 2014 Mar 17;3:e91
  • Nader J, Rapino C, Gennequin B, Chavant F, Francheteau M, Makriyannis A, Duranti A, Maccarrone M, Solinas M, Thiriet N. ≪ Prior stimulation of the endocannabinoid system prevents methamphetamineinduced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors≫ Neuropharmacology. 2014 Dec;87:214-21.
  • Balbous A, Renoux B, Cortes U, Milin S, Guilloteau K, Legigan T, Rivet P, Boissonnade O, Martin S, Tripiana C, Wager M, Bensadoun RJ, Papot S, Karayan-Tapon L. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma. Mol Cancer Ther. 2014 Sep;13(9):2159-69.
  • Destaing O, Petropoulos C, Albiges-Rizo C. “Coupling between acto-adhesive machinery and ECM degradation in invadosomes”, Cell Adhesion & Migration;01 May 2014.
  • Karayan-Tapon L, Cortes U, Rivet P, Jermidi C, Vassal G, Wager M, Taillandier L. Lack of GOPC-ROS1 (FIGROS1)rearrangement in adult human gliomas. Eur J Cancer. 2014 Sep;50(13):2364-6.
  • Quillien V, Lavenu A, Sanson M, Legrain M, Dubus P, Karayan-Tapon L, Mosser J, Ichimura K, Figarella-Branger D. (2014) Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients. J Neurooncol. 116(3):487-96.
  • Brot S, Smaoune H, Youssef-Issa M, Malleval C, Benetollo C, Besancon R, Auger C, Moradi-Ameli M, Honnorat J. Collapsin response-mediator protein 5 (CRMP5) phosphorylation at threonine 516 regulates neurite outgrowth inhibition. Eur J Neurosci. 2014 Oct;40(7):3010-20.
  • Brot S, Auger C, Bentata R, Rogemond V, Menigoz S, Chounlamountri N, Girard-Egrot A, Honnorat J, Moradi-Ameli M. Collapsin response mediator protein 5 (CRMP5) induces mitophagy, thereby regulating mitochondrion numbers in dendrites. J Biol Chem. 2014 Jan 24;289(4):2261-76.
  • Betemps D, Verchere J, Brot S, Morignat E, Bousset L, Gaillard D, Lakhdar L, Melki R, Baron T. Alphasynuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA. Acta Neuropathol Commun. 2014 Mar 13;2:29.
  • Pontini S, Fleurat-Lessard P, Bere E, Berjeaud JM, Roblin G ≪ Impact of temperature variations on toxic effects of the polypeptides secreted by Phaeoacremonium aleophilum ≫ PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY,2014 Volume: 87 Pages: 51-58
  • Nader J, Rapino C, Gennequin B, Chavant F, Francheteau M, Makriyannis A, Duranti A, Maccarrone M, Solinas M, Thiriet N. ≪ Prior stimulation of the endocannabinoid system prevents methamphetamineinduced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. ≫ Neuropharmacology. 2014 Dec;87:214-21.
  • Chauvet C., Nicolas C, Thiriet N, Lardeux MV, Duranti A, Solinas M ≪ chronic stimulation of the tone endogenous anandamide reduces cue-and stress-induced relapse in rats ≫ International Journal of Neuropsychopharmacology 2014 Dec 5 ;18 (1)
  • Lepelletier FX, Tauber C, Nicolas C, Solinas M, Castelnau P, Belzung C, Emond P, Cortese, Faraone SV, Chalon S, Galineau L ≪ prenatal exposure to methylphenidate affects the dopamine system and the reactivity to natural reward in adulthood in rats ≫ Int J Neuropsychopharmaoclogy 2014 Oct 31 ; 18(4)
  • Ansquer S, Belin-Rauscent A, Dugast E, Duran T, Benatru I, Mar AC, Houeto JL, Belin D. ≪ Atomoxetine decreases vulnerability to develop compulsivity in high impulsive rats. ≫ Biological Psychiatry. 2014 May 15;75(10):825-32.
  • Belujon P, Patton, MH, Grace AA ≪ Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plsticity in a developmental animal model of schizophrenia ≫ Cerebral Cortex. 2014 Apr;24(4):968-77.
  • Belujon P, Grace AA ≪ Restoring mood balance in depression : ketamine reverses deficits in dopaminedependent synaptic plqsticity≫ Biological Psychiatry. 2014 Dec 15;76(12):927-36.
  • Bassil F, Fernagut PO, Bezard E, Meissner WG: Insulin, IGF-1 and GLP-1 signaling in neurodegenerative
    disorders: targets for disease modification? Prog Neurobiol 2014; 118: 1-18
  • Bezard E, Fernagut PO: Premotor parkinsonism models. Parkinsonism Relat Disord 2014; 20 Suppl 1: S17-9
  • Fernagut PO, Dehay B, Maillard A, Bezard E, Perez P, Pavy-Le Traon A, Rascol O, Foubert-Samier A, Tison F, Meissner WG: Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies. Neurobiol Dis 2014; 67: 133-9

Recherche

Menu principal

Haut de page